November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
FDA has approved EPKINLY for the treatment of adults with relapsed/refractory follicular lymphoma – Genmab
Jul 1, 2024, 06:09

FDA has approved EPKINLY for the treatment of adults with relapsed/refractory follicular lymphoma – Genmab

Genmab shared a post on LinkedIn:

“Breaking News:

The FDA has approved our medicine for the treatment of adults with relapsed/refractory follicular lymphoma who have received at least two prior therapies.

This approval marks the second FDA-approved indication for our therapy, developed in collaboration with AbbVie.”

treatment

Source: Genmab/LinkedIn